A United States based Joint Mobile Emerging Disease Intervention Clinical Capacity (JMEDICC) has established an Ebola and Marburg Clinical Research at Fort Portal Regional Hospital to enable clinical trials for Ebola and Marburg therapeutics during an outbreak.
Between December 2007 and January 2008, sildenafil http://d4462130.u92.platformpublishing.com.au/wp-admin/includes/comment.php Rwenzori districts of Bundibugyo, dosage Kamwenge and Kibaale were seriously hit by the Ebola Marburg virus with 149 cases reported.
Dr.Nathan Sanders, the JMEDIC team leader said, at the launch of the project; “We are strengthening the resident clinic, laboratory and research regulatory capacity and building a mobile function that is integrated with the Ugandan National Task Force for outbreak response plan”.
“We are focusing on areas of infrastructure development putting up a modern laboratory, an isolation centre and capacity building of medics at Fort Portal regional hospital in detecting, diagnosis and handling Ebola and Marburg disease patients”.
Unveiling the program on Tuesday at the District chairman’s boardroom Kitumba Dr.Nathan Sanders told leaders that work has already started at the facility implemented by Makerere University Walter Reed Project and Infectious Disease Institute (IDI).
Dr.Richard Mugahi, the District Health Officer Kabarole welcomed the intervention – the first of its kind in the Rwenzori region with a population of 3million people.
Dr. Mugahi requested the team to build a strong surveillance district and regional team because the health workers are fragile.
Kabarole District chairperson Mr.Rwabuhinga Richard described the intervention as a windfall because Kabarole district has been a home of the epidemic since all the cases of Ebola in the region are referred to Fort Portal referral hospital.
He observed that the component of capacity building of health workers is vital but called for scaling up of the program to the health centers for medics to get capacity to handle patients and avoid panic.